Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish

Hong Wei Yang1, Jeffery L Kutok, Nam Hyuk Lee

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Cancer Research
|October 20, 2004
PubMed

Insights

Researchers developed a zebrafish model for pancreatic neuroendocrine carcinoma by targeting MYCN expression. This model aids in studying cancer development and evaluating MYCN

Area of Science:

  • Comparative oncology
  • Zebrafish as a model organism
  • Cancer genetics

Background:

  • Zebrafish are valuable for studying genetic pathways in development.
  • The MYCN oncogene plays a role in various cancers.
  • A need exists for effective models of pancreatic neuroendocrine carcinoma.

Purpose of the Study:

  • To establish a zebrafish transgenic model for pancreatic neuroendocrine carcinoma.
  • To investigate the role of MYCN in inducing this specific cancer type.
  • To provide a platform for studying MYCN-driven cancer pathways.

Main Methods:

  • Targeted MYCN gene expression in zebrafish pancreatic islet cells.
  • Histologic and immunohistochemical analysis of induced tumors.
  • Transmission electron microscopy to examine cellular ultrastructure.

Main Results:

  • Transgenic zebrafish developed abdominal tumors resembling neuroendocrine carcinoma.
  • Tumors showed MYCN transgene expression and insulin mRNA.
  • Histology confirmed pancreatic origin and presence of endocrine-dense core granules.

Conclusions:

  • A novel zebrafish model for pancreatic neuroendocrine carcinoma has been established.
  • This model facilitates the study of MYCN's role in pancreatic cancer.
  • The model is suitable for future research on MYCN-driven molecular pathways.

Related Concept Videos